HPC — Hydration Pharmaceuticals Co Share Price
Last trade - 00:00- AU$9.33m
- AU$7.83m
- $9.10m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.53 | ||
| Price to Tang. Book | 1.53 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.67 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -137.49% | ||
| Return on Equity | -123.29% | ||
| Operating Margin | -116.56% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 4.16 | 2.96 | 3.76 | 6.13 | 9.1 | n/a | n/a | 21.61% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
The Hydration Pharmaceuticals Company Limited is an Australia-based consumer products company. The Company markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has its operations in Canada, United States and Australia. Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, Hydration Pharmaceutical Service Pty Ltd, and Hydration Therapeutics UK Limited.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- July 24th, 2017
- Public Since
- December 14th, 2021
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 163,755,295
- Address
- 525 Collins Street, MELBOURNE, 3000
- Web
- Phone
- Auditors
- PricewaterhouseCoopers Securities Ltd
Upcoming Events for HPC
Similar to HPC
Acrux
Australian Stock Exchange - SEATS
AFT Pharmaceuticals
Australian Stock Exchange - SEATS
Auscann group
Australian Stock Exchange - SEATS
Biome Australia
Australian Stock Exchange - SEATS
Botanix Pharmaceuticals
Australian Stock Exchange - SEATS
FAQ
As of Today at 13:22 UTC, shares in Hydration Pharmaceuticals Co are trading at AU$0.06. This share price information is delayed by 15 minutes.
Shares in Hydration Pharmaceuticals Co last closed at AU$0.06 and the price had moved by -76.73% over the past 365 days. In terms of relative price strength the Hydration Pharmaceuticals Co share price has underperformed the ASX All Ordinaries Index by -76.66% over the past year.
There is no consensus recommendation for this security.
Hydration Pharmaceuticals Co does not currently pay a dividend.
Hydration Pharmaceuticals Co does not currently pay a dividend.
Hydration Pharmaceuticals Co does not currently pay a dividend.
To buy shares in Hydration Pharmaceuticals Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.06, shares in Hydration Pharmaceuticals Co had a market capitalisation of AU$9.33m.
Here are the trading details for Hydration Pharmaceuticals Co:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: HPC
Based on an overall assessment of its quality, value and momentum Hydration Pharmaceuticals Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hydration Pharmaceuticals Co. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -51.84%.
As of the last closing price of AU$0.06, shares in Hydration Pharmaceuticals Co were trading -56.31% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hydration Pharmaceuticals Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Hydration Pharmaceuticals Co's directors